ARCHIVES

Von Eschenbach To Leave FDA Jan. 20, Says He Was “In Love” With The Agency.

This article is from The Cancer Letter archive.

Vol. 34 No. 46 | December 19, 2008

Download PDF Visit The Full Archive

Related Articles

In brief: ring appointed Associate Dean At UCSF; Univ. of Utah Forms Cell Signaling Center

August 1, 1997

Clinical Trials: Phase I Trial of Karenitecin Begins, BioNumerik Says

March 5, 1999

MUSC Hollings Cancer Center awarded NCI designation

February 1, 2021

NCI RFPs Available. RFAs Available. Program Announcements.

January 14, 2000

NCI Programs: Institute To Expand Career Development, Training Grants

December 18, 1998

FDA Rejects Genentech Bid For Accelerated Approval For T-DM1. NCI Breaks Ground For Satellite Campus At Shady Grove

September 3, 2010